Translumina Therapeutics Llp

Manufactures and deals in medical devices, acts as a consultant.

2009 | Delhi, Delhi (India) | Active
Last Updated:

Translumina Therapeutics Llp Profile

Key Indicators

  • Obligation of Contribution ₹ 0.10 M
  • Company Age 15 Year, 3 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 60.95 Cr
  • Satisfied Charges ₹ 9.25 Cr
  • Revenue Growth -11.84%
  • Profit Growth -36.98%
  • Ebitda -17.32%
  • Total Assets -1.80%

About Translumina Therapeutics Llp

Translumina Therapeutics Llp (TTL) is 15 Year, 3 Months old Limited Liability Partnership 01 December 2009. Its registered office is in Delhi, Delhi.

The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.

Company Details

Corporate Identity Details

  • CIN/LLPIN/FCRN

    AAA-0435

  • Incorporation Date

    01 Dec 2009

  • Date of Accounts and Solvency Statement

    31 Mar 2023

  • ROC Code

    Roc-Delhi

  • Company Classification

    Limited Liability Partnership

Industry

Healthcare

Who are the key members and board of directors at Translumina Therapeutics Llp?

Designated Partners (4)

NameDesignationAppointment DateStatus
Vishal Sharma Country flag representing In Designated Partner 11-Mar-2020Current
Punita Sharma Country flag representing In Designated Partner 01-Dec-2009Current
Indranil Mukherjee Country flag representing In Designated Partner 15-Mar-2024Current
Vishal Goenka Country flag representing In Designated Partner 15-Mar-2024Current

Financial Performance of Translumina Therapeutics Llp.

Translumina Therapeutics Llp, for the financial year ended 2021, experienced significant reduction in revenue, with a 11.84% decrease. The company also saw a substantial fall in profitability, with a 36.98% decrease in profit. The company's net worth witnessed no change by increase of 0%.

Translumina Therapeutics Llp revenue growth over time
Translumina Therapeutics Llp profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-11.84%
Revenue from Operations
-12.60%
Total Assets
-1.80%
Profit or Loss
-36.98%
Net Worth
EBITDA
-17.32%

What is the Ownership and Shareholding Structure of Translumina Therapeutics Llp?

Unlock access to Translumina Therapeutics Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹609.50 M

Satisfied Charges

₹92.50 M

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 50.55 Cr
  • Icici Bank Limited : 10.00 Cr
  • Axis Bank Limited : 0.40 Cr

Latest Charge Details

DateLenderAmountStatus
18 Nov 2022Hdfc Bank Limited₹2.30 MOpen
30 Aug 2022Icici Bank Limited₹10.00 CrOpen
20 Apr 2022Hdfc Bank Limited₹1.61 MOpen
28 Jan 2022Hdfc Bank Limited₹50.00 CrOpen
27 Nov 2021Hdfc Bank Limited₹0.80 MOpen

How Many Employees Work at Translumina Therapeutics Llp?

Translumina Therapeutics Llp has a workforce of 363 employees as of Feb 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Translumina Therapeutics Llp

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Translumina Therapeutics Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Translumina Therapeutics Llp's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Translumina Therapeutics Llp

Recent activity within the organization

  • Director Appointment

    Indranil Mukherjee was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2024 & has been associated with this company since 11 months 20 days .

  • Director Appointment

    Vishal Omprakash Goenka was appointed as a Designated Partner was appointed as a Designated Partner on 15 Mar 2024 & has been associated with this company since 11 months 20 days .

  • Statement of Assets & Liabilities

    Translumina Therapeutics Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with RoC-Delhi.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 500.00 M registered on 28 Jan 2022 with Charge ID 100534152 was modified on 21 Mar 2023.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 2.30 M with Charge ID 100654416 was registered on 18 Nov 2022.

  • Charges

    A charge registered on 13 Aug 2014 via Charge ID 100104055 with Kotak Mahindra Bank Limited was fully satisfied on 05 Sep 2022.

Frequently asked questions

  • What is the Incorporation or founding date of Translumina Therapeutics Llp?

    Translumina Therapeutics Llp was incorporated on 01 Dec 2009.

  • What is Obligation of Contribution of Translumina Therapeutics Llp?

    The Obligation of Contribution of Translumina Therapeutics Llp is ₹ 0.10 M.

  • Who are the current designated partners & partners of Translumina Therapeutics Llp?

    Currently 4 partners are associated with Translumina Therapeutics Llp.

    • Punita Sharma
    • Vishal Sharma
    • Indranil Mukherjee
    • Vishal Omprakash Goenka
    Punita SharmaVishal SharmaIndranil MukherjeeVishal Omprakash Goenka

  • What is the registered address of Translumina Therapeutics Llp?

    As per Ministry of Corporate Affairs (Mca), the registered address of Translumina Therapeutics Llp is Ground Floor Metro Tower Lsc Mor Land, New Rajinder Nagar Na Central, Delhi, India, 110060.

  • What is the Limited Liability Partnership Identification Number (LLPIN) of Translumina Therapeutics Llp?

    The Limited Liability Partnership Identification Number (LLPIN) of Translumina Therapeutics Llp is AAA-0435.

  • What is the official website of Translumina Therapeutics Llp?

    The Official website of Translumina Therapeutics Llp is https://www.translumina.com

  • What has been the recent revenue trend for Translumina Therapeutics Llp?

    According to the financial reports for the fiscal year 2021, the revenue trend for Translumina Therapeutics Llp has fallen by -11.84%.

  • How many employees does Translumina Therapeutics Llp currently have?

    As Per 2021 financial reports, 363 employees are currently employed by Translumina Therapeutics Llp.

  • What are the total open charges for Translumina Therapeutics Llp?

    As per the financial statements for fiscal Year 2021, The total open charges for Translumina Therapeutics Llp amount to ₹ 60.95 Cr.

  • When was the last Balance Sheet of Translumina Therapeutics Llp filed with the ROC?

    The most recent Balance Sheet for Translumina Therapeutics Llp was filed with the ROC on 31 Mar 2023.